| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group* Annals of internal medicine 151 (4), 264-269, 2009 | 143312 | 2009 |
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies E Von Elm, DG Altman, M Egger, SJ Pocock, PC Gøtzsche, ... The lancet 370 (9596), 1453-1457, 2007 | 52960* | 2007 |
| Bias in meta-analysis detected by a simple, graphical test M Egger, GD Smith, M Schneider, C Minder bmj 315 (7109), 629-634, 1997 | 50709 | 1997 |
| CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ... Bmj 340, 2010 | 10898 | 2010 |
| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... Annals of internal medicine 147 (8), W-163-W-194, 2007 | 10740 | 2007 |
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies AG Renehan, M Tyson, M Egger, RF Heller, M Zwahlen The lancet 371 (9612), 569-578, 2008 | 6606 | 2008 |
| The revised CONSORT statement for reporting randomized trials: explanation and elaboration DG Altman, KF Schulz, D Moher, M Egger, F Davidoff, D Elbourne, ... Annals of internal medicine 134 (8), 663-694, 2001 | 4700 | 2001 |
| Assessing the quality of controlled clinical trials P Jüni, DG Altman, M Egger Bmj 323 (7303), 42-46, 2001 | 4586* | 2001 |
| Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration JPT Higgins, S Green London, UK, 2011 | 3920* | 2011 |
| Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis JAC Sterne, M Egger Journal of clinical epidemiology 54 (10), 1046-1055, 2001 | 3550 | 2001 |
| Meta-analysis: principles and procedures M Egger, GD Smith, AN Phillips Bmj 315 (7121), 1533-1537, 1997 | 3468* | 1997 |
| Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ... The Lancet 391 (10128), 1357-1366, 2018 | 3389 | 2018 |
| Systematic reviews in health care: meta-analysis in context M Egger, G Davey-Smith, D Altman John Wiley & Sons, 2008 | 2919 | 2008 |
| Systematic reviews in health care: meta-analysis in context M Egger, G Davey-Smith, D Altman John Wiley & Sons, 2008 | 2919 | 2008 |
| Investigating and dealing with publication and other biases in meta-analysis JAC Sterne, M Egger, GD Smith Bmj 323 (7304), 101-105, 2001 | 2554 | 2001 |
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study L Wood, M Egger, LL Gluud, KF Schulz, P Jüni, DG Altman, C Gluud, ... bmj 336 (7644), 601-605, 2008 | 2427 | 2008 |
| Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature JAC Sterne, D Gavaghan, M Egger Journal of clinical epidemiology 53 (11), 1119-1129, 2000 | 2325 | 2000 |
| The hazards of scoring the quality of clinical trials for meta-analysis P Jüni, A Witschi, R Bloch, M Egger Jama 282 (11), 1054-1060, 1999 | 2303 | 1999 |
| Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, ... The Lancet 360 (9327), 119-129, 2002 | 2133 | 2002 |
| Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis AG Renehan, M Zwahlen, C Minder, S T O'Dwyer, SM Shalet, M Egger The Lancet 363 (9418), 1346-1353, 2004 | 2129 | 2004 |
Douglas G AltmanCentre for Statistics in Medicine, University of OxfordVerified email at csm.ox.ac.uk
